ZARVY

Foracort 200 Inhaler contains Formoterol Fumarate (6mcg) and Budesonide (200mcg), an effective combination therapy for asthma and chronic obstructive pulmonary disease (COPD). Formoterol: A long-acting beta-2 adrenergic agonist (LABA) that relaxes airway muscles, improving airflow and preventing bronchoconstriction. Budesonide: An inhaled corticosteroid (ICS) that reduces lung inflammation and prevents asthma attacks. Foracort 200 is recommended for long-term asthma control and COPD maintenance therapy, helping to prevent wheezing, shortness of breath, and airway inflammation.

Duolin Inhaler - 200 MDI contains Levosalbutamol 50mcg and Ipratropium 20mcg, a combination bronchodilator therapy for asthma and chronic obstructive pulmonary disease (COPD). Levosalbutamol (Levalbuterol): Selective beta-2 adrenergic agonist, relaxes airway muscles, reduces bronchospasm, and improves airflow. Ipratropium: An anticholinergic agent that blocks muscarinic receptors, preventing mucus overproduction and airway constriction. Together, they provide dual-action bronchodilation, ideal for COPD, chronic bronchitis, emphysema, and asthma exacerbations. The Metered Dose Inhaler (MDI) ensures precise dosing for consistent symptom control and fast relief during acute respiratory distress, including exercise-induced bronchospasm.

Formost 200 Inhaler is a combination controller inhaler for the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol Fumarate (6mcg): A long-acting beta-2 adrenergic agonist (LABA) that relaxes airway muscles and maintains airflow for up to 12 hours. Mometasone (200mcg): An inhaled corticosteroid (ICS) that reduces airway inflammation and mucus production. This metered-dose inhaler (MDI) delivers precise medication per puff, helping maintain stable lung function, reduce exacerbations, and lower the need for rescue inhalers.

Serevent Evohaler is the original brand inhaler manufactured by GSK, containing Salmeterol 25mcg, a long-acting beta-2 adrenergic agonist (LABA) used for the prevention of asthma symptoms and long-term management of chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles in the airways to improve breathing and is effective for up to 12 hours. This inhaler is not suitable for acute asthma attacks but is essential in maintaining airway patency and controlling chronic symptoms.

Flixonase Nasal Spray - 120 MDI is an original branded medication manufactured by GSK, containing Fluticasone Propionate 50mcg per spray. It belongs to the class of inhaled corticosteroids (ICS) and is specifically formulated for intranasal administration. Flixonase is widely used for managing chronic allergic rhinitis, seasonal hay fever, and nasal polyps, by targeting the root cause of inflammation in the nasal passages. This nasal spray reduces the local inflammatory response triggered by allergens, such as pollen, dust mites, and pet dander, by suppressing the release of inflammatory mediators like histamines and cytokines. As part of the Respiratory Diseases category, Flixonase provides long-lasting relief from nasal congestion, sneezing, itchy nose, and postnasal drip, making it a mainstay in allergy control regimens. Unlike systemic corticosteroids, it delivers the medication directly to the nasal mucosa, resulting in minimal systemic absorption and reduced risk of side effects.

Serevent Accuhaler is an original branded medication manufactured by GSK, containing Salmeterol 50mcg, a long-acting β2-adrenergic receptor agonist (LABA). It is formulated as an inhalation powder in a user-friendly Accuhaler device, designed to deliver a consistent dose directly to the lungs. This medication plays a crucial role in managing chronic respiratory diseases by promoting bronchodilation and improving airflow in patients with Asthma and Chronic Obstructive Pulmonary Disease (COPD). As a maintenance therapy, Serevent Accuhaler helps prevent breathing difficulties, wheezing, and chest tightness. Its long-acting nature provides symptom relief for up to 12 hours, making it especially effective for nighttime symptom control and long-term airway management. It is not intended for immediate relief of acute asthma attacks, but rather as part of a regular respiratory care routine.

Onbrez 300 Breezhaler is an original inhalation medication by Novartis, containing Indacaterol 300mcg, a once-daily ultra-long-acting β2 agonist (LABA). It delivers powerful and sustained bronchodilation for the maintenance treatment of severe COPD (Chronic Obstructive Pulmonary Disease), including chronic bronchitis and emphysema. The Breezhaler® device ensures precise and efficient pulmonary delivery. In respiratory care, Onbrez 300 stands alongside treatments such as Omnacortil (for inflammation) and antibiotics like Zithromax, Vibramycin, or Novamox, which are often used when COPD patients suffer bacterial exacerbations. Many patients also find this product conveniently available via an online pharmacy.

Derinide 40 Nasal Spray is a generic intranasal corticosteroid (ICS) formulation containing Budesonide 64mcg per spray, specifically designed to manage nasal inflammation and respiratory symptoms associated with allergic and non-allergic rhinitis. As an inhaled corticosteroid, Budesonide provides targeted anti-inflammatory action within the nasal passages, making it highly effective in reducing nasal congestion, runny nose, sneezing, and sinus pressure. This medication plays a vital role in the Respiratory Diseases category, particularly within the subcategory of Inhaled Corticosteroids (ICS). Derinide 40 is often used as a first-line treatment for seasonal allergic rhinitis, perennial rhinitis, and nasal polyps, as well as a supportive therapy in patients with asthma who exhibit upper airway involvement. Its localized action ensures minimal systemic absorption, providing effective symptom relief with a favorable safety profile, even during long-term use.

Furamist Nasal Spray is a generic equivalent of Flixonase, containing Fluticasone Propionate 27.5mcg per spray. It is a topical corticosteroid specifically formulated for nasal administration to relieve symptoms of seasonal and perennial allergic rhinitis, including sneezing, runny or itchy nose, and nasal congestion. Its anti-inflammatory action makes it highly effective for daily management of nasal allergy symptoms.

Levolin 50mcg Inhaler is a bronchodilator containing Levosalbutamol 50mcg, which is widely used to relieve bronchospasms and improve airflow in patients with asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. As a beta-2 adrenergic agonist, Levosalbutamol works by relaxing the smooth muscles in the airways, making it easier to breathe. It provides rapid relief from wheezing, shortness of breath, and chest tightness. Unlike standard Salbutamol, Levosalbutamol is considered to have a more selective action on bronchial muscles, reducing the risk of unwanted side effects such as tremors and palpitations. It is commonly prescribed for asthma maintenance therapy, exercise-induced bronchoconstriction, and acute episodes of airway obstruction. This metered-dose inhaler (MDI) ensures precise dosing for effective symptom control.

Formonide 100 Inhaler contains Formoterol Fumarate 6mcg (a long-acting bronchodilator) and Budesonide 100mcg (a corticosteroid), making it an effective combination inhaler for managing asthma and chronic obstructive pulmonary disease (COPD). Formoterol works by relaxing airway muscles, making breathing easier, while Budesonide reduces airway inflammation and prevents asthma attacks. This inhaler is recommended for long-term asthma control and COPD symptom management, helping to prevent wheezing, shortness of breath, and airway obstruction.

Formonide 200 Inhaler contains Formoterol Fumarate (6mcg) and Budesonide (200mcg), making it an effective combination inhaler for asthma and chronic obstructive pulmonary disease (COPD) management. Formoterol: A long-acting bronchodilator (LABA) that relaxes airway muscles, improving airflow and preventing airway constriction. Budesonide: A corticosteroid that reduces inflammation in the lungs and prevents asthma attacks. Formonide 200 is recommended for long-term asthma control and COPD maintenance, preventing wheezing, shortness of breath, and respiratory inflammation.

Budecort 200 Inhaler is a generic inhaled corticosteroid (ICS) formulation containing Budesonide 200mcg, designed for long-term management of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Budesonide is a potent glucocorticoid with powerful anti-inflammatory properties, helping to reduce airway hyperresponsiveness and prevent exacerbations in both children and adults. This inhaler is part of the inhaled corticosteroids (ICS) class, which is central to standard therapy for Respiratory Diseases. It helps manage chronic airway inflammation by targeting the underlying causes of symptoms rather than just providing symptomatic relief. Patients using Budecort 200 Inhaler often experience improved breathing patterns, reduced wheezing, and fewer nighttime awakenings due to breathlessness. It is suitable for maintenance therapy, but it is not a rescue medication for acute asthma attacks. When used consistently, Budecort reduces reliance on short-acting bronchodilators, offering better lung function and quality of life over time.

Flutiflo Nasal Spray is a generic formulation of Flixonase, containing Fluticasone Propionate 50mcg per spray. It is a topical corticosteroid used for managing nasal symptoms associated with allergic rhinitis, including sneezing, runny nose, nasal congestion, and itching. Its potent anti-inflammatory properties make it a first-line treatment for seasonal allergies and year-round nasal sensitivities.

Nazomac-F Nasal Spray is a generic nasal corticosteroid formulation containing Fluticasone 50mcg, designed to effectively relieve nasal symptoms associated with allergic and non-allergic rhinitis. As part of the Inhaled Corticosteroid (ICS) class within Respiratory Diseases, this spray works by suppressing inflammation in the nasal passages, reducing congestion, sneezing, itching, and runny nose. It is commonly used in both seasonal allergic rhinitis (hay fever) and perennial rhinitis. Fluticasone is a potent anti-inflammatory agent that acts locally without significant systemic absorption, making Nazomac-F a safe and effective long-term option for patients who suffer from chronic nasal issues. Its once-daily dosing and minimal systemic side effects improve patient adherence and quality of life. It can also be used adjunctively in asthma patients with upper airway inflammation, forming a part of comprehensive respiratory management.

Seroflo 250 Inhaler is a combination inhalation therapy containing Fluticasone 250mcg and Salmeterol 25mcg, designed for the long-term management of chronic respiratory diseases such as asthma and COPD. Fluticasone is a potent inhaled corticosteroid (ICS) that suppresses inflammation in the airways, while Salmeterol is a long-acting beta-agonist (LABA) that relaxes bronchial muscles and improves airflow. This synergistic formulation provides both anti-inflammatory and bronchodilating effects, making it an essential component in the maintenance treatment of moderate to severe asthma and COPD. The Metered Dose Inhaler (MDI) format ensures consistent delivery of the medication directly to the lungs, minimizing systemic exposure and enhancing local efficacy. It is particularly effective for patients who experience frequent respiratory symptoms, nocturnal wheezing, or exercise-induced breathlessness. Seroflo 250 falls under the Respiratory Diseases category and is a reliable option for preventing exacerbations and maintaining long-term pulmonary stability.

Foracort 400 Inhaler is a combination therapy inhaler containing Formoterol Fumarate (6mcg) and Budesonide (400mcg), specifically designed to manage moderate to severe asthma and chronic obstructive pulmonary disease (COPD). This dual-action metered-dose inhaler (MDI) effectively controls airway inflammation and persistent breathing difficulties by combining a long-acting bronchodilator (Formoterol) with an inhaled corticosteroid (Budesonide). Formoterol acts as a long-acting beta-2 agonist (LABA), relaxing airway muscles and providing relief from bronchospasms for up to 12 hours. It ensures smooth breathing and improved airflow, making it effective in preventing nighttime asthma attacks and exercise-induced bronchospasms. Budesonide, a powerful corticosteroid, reduces lung inflammation, swelling, and mucus production, preventing chronic respiratory distress and recurrent asthma symptoms. Foracort 400 Inhaler is ideal for long-term respiratory management, reducing the need for emergency bronchodilators while improving lung function over time. It is not a rescue inhaler and should be used consistently to maintain optimal airway health.

Formonide 400 Inhaler is a combination metered-dose inhaler (MDI) containing Formoterol Fumarate (6mcg) and Budesonide (400mcg), designed for long-term asthma and COPD (chronic obstructive pulmonary disease) management. This inhaler is a dual-action therapy that provides both bronchodilation and anti-inflammatory effects, improving lung function and preventing respiratory symptoms. Formoterol, a long-acting beta-2 agonist (LABA), works by relaxing airway muscles, allowing better airflow and preventing sudden bronchospasms. Budesonide, an inhaled corticosteroid (ICS), reduces inflammation and mucus production, preventing frequent asthma attacks and COPD exacerbations. As an MDI, Formonide 400 ensures controlled and accurate medication delivery with each dose, making it ideal for daily maintenance therapy. However, it is not a rescue inhaler and should not be used to treat acute breathing difficulties.